Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Hypomethylating agents plus venetoclax versus intensive chemotherapy prior to transplant in high-risk acute myeloid leukemia

Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille
Yale University, New Haven, CT
Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille
Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille
Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Memorial Sloan Kettering Cancer Center, New York, NY
Moffitt Cancer Center, Tampa, FL
Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos and Vilnius University, Faculty of Medicine, Vilnius, Lithuania
Duke University Medical Center, Durham, NC
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Yale University, New Haven, CT
Yale University, New Haven, CT
Service d’hématologie et de thérapie cellulaire, CHU Clermont-Ferrand, Clermont-Ferrand
Yale University, New Haven, CT
Memorial Sloan Kettering Cancer Center, New York, NY
Yale University, New Haven, CT
CHU de Bordeaux, Service Hématologie Clinique et Thérapie Cellulaire, UMR 5164, F-33000 Bordeaux
Hematology Department, Nice University Hospital, Cote d’Azur University, Nice
CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, BRIC (BoRdeaux Institute of onCology), UMR1312, INSERM, Université de Bordeaux, Bordeaux
Hospices Civils de Lyon, Hôpital Lyon Sud, Service d'hématologie Clinique Lyon France
Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
Memorial Sloan Kettering Cancer Center, New York, NY
Yale University, New Haven, CT
Aix-Marseille University, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille
Haematologica Early view Apr 2, 2026 https://doi.org/10.3324/haematol.2025.300202

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.300202
Pubmed
41924924
 
Published
2026-04-02
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
153
PDF Downloads
91

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online